Navigation Links
Romark Announces Data Presented at AASLD Meeting 2010
Date:11/1/2010

TAMPA, Fla., Nov. 1, 2010 /PRNewswire/ -- Romark Laboratories announced that data from studies of nitazoxanide in hepatitis C are being presented at the 61st Annual Meeting of the American Association for the Study of Liver Diseases (AASLD), also known as The Liver Meeting® in Boston, October 30 – November 2, 2010.

(Logo: http://www.newscom.com/cgi-bin/prnh/20100201/FL47022LOGO)

(Logo: http://photos.prnewswire.com/prnh/20100201/FL47022LOGO)

"The data presented at AASLD provide important support for our ongoing clinical development program for nitazoxanide in chronic hepatitis C (CHC)," said Jean-Francois Rossignol, M.D., Ph.D., Chairman and Chief Science Officer of Romark.  "Extensive studies have shown that nitazoxanide does not induce mutations that confer viral resistance – one of the most challenging problems associated with antiviral therapy.  Other studies highlight the important role of nitazoxanide in stimulating the interferon signaling pathway and a potential role for nitazoxanide in special populations such as relapsers and liver transplant patients."  

Another major finding reported at AASLD is the activity of nitazoxanide-related compounds (called thiazolides) against HCV.  Collectively, these studies provide further rationale for the use of nitazoxanide and other thiazolides as part of a new approach to chronic hepatitis C therapy – an approach that focuses on reducing the number of drugs and the toxicities associated with treatment.

Investigators from Georgetown University, the National Institutes of Health, and Mayo Clinic have presented or will present their data on October 31 and November 2.  The three presentations are listed and described briefly below:

1. HCV Resistance to Nitazoxanide is not due to Changes in the Viral Sequence.  Brent Korba, Microbiology & Immunology, Georgetown Univ. Med. Ctr., Washington, DC. Poster session: T
'/>"/>

SOURCE Romark Laboratories, L.C.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Romark and Intercell Join Forces in Combining Therapies Against Hepatitis C
2. Intercell and Romark Join Forces in Combining Therapies Against Hepatitis C
3. NeuroFocus and New Scientist Magazine Apply Neuromarketing to Select Cover Design
4. Romark Initiates Clinical Trial of Alinia for Treatment of Influenza
5. Romark Laboratories Completes Enrollment in U.S. Phase II Study of Nitazoxanide for Chronic Hepatitis C Genotype 1 Non-Responders
6. Romark Announces Presentation of New Data for Nitazoxanide in Chronic Hepatitis C at EASL 2008
7. Romark Laboratories Initiates Phase II Study of Nitazoxanide in Treatment-Naive Patients With Chronic Hepatitis C Genotype 1
8. Romark Laboratories Raises $18 Million in Institutional Financing
9. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
10. AVANIR Pharmaceuticals Announces FDA Approval of NUEDEXTA™
11. Stryker Announces Acquisition of Privately-Held Porex Surgical
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... AARP Foundation today announced it has established a ... the severe cold weather that has gripped much of ... helping those in need; so to support these emergency ... contributions up to $250,000, which could mean up to ... through AARP Foundation. (Logo: http://photos.prnewswire.com/prnh/20070209/NYF043LOGO ...
(Date:1/15/2014)... OAKS, Calif. , Jan. 15, 2014 /PRNewswire/ ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ... in clinical medicine, IBD biology, human genetics, genomic ...
(Date:1/15/2014)... -- BreedIT Corp (OTC: BRDT), through its ... highly sophisticated agro-breeding solutions for plant breeders and researchers, ... board of directors appointed chemistry and pharmaceutical industry expert ... of the board. From 1975 to 2012, ... Ltd (NYSE: TEVA ) and its subsidiaries ...
Breaking Medicine Technology:AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 2AARP Foundation Establishes Winter Relief Fund for Older Adults Suffering from the Severe Cold Weather 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 2BreedIT (OTC: BRDT) Appoints Chemistry and Pharmaceutical Industry Expert Dr. Ben-Zion Weiner to Its Board of Directors 3
... 20 The District of Columbia Patients, Cooperative ... the District of Columbia, has submitted comments to the ... on proposed regulations announced 45 days ago.   ... http://www.dcpatients.org/DCPC_comments.pdf along with the comments of cannabis ...
... NewBridge Pharmaceuticals FZ-LLC of Dubai, UAE announced today that ... Executive Officer and a member of the company,s Board ... joins NewBridge after a career extending over 29 years ... positions covering many geographies including; US, Europe, and Middle ...
Cached Medicine Technology:DC Patients' Cooperative Urges Changes to the Proposed Medical Cannabis 'Marijuana' Regulations 2NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments 2NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments 3
(Date:4/14/2014)... orphaned by HIV/AIDS in South Africa may provide insight ... behavior issues in other areas of the world, which ... that could lead to successful interventions. , A ... United Nations mentions that due to the HIV/AIDS pandemic, ... African, children are at an increased risk for mental ...
(Date:4/14/2014)... A new study shows that moderate to severe ... risk of stroke, cancer and death. , Results of ... to severe obstructive sleep apnea were four times more ... times more likely to have a stroke (HR = ... (HR = 3.4), and 2.5 times more likely to ...
(Date:4/14/2014)... Dallas study involving serious youth offenders, the answer to one ... seven years: "How long do you think you,ll live?", According ... offending over time., Author Dr. Alex Piquero said the study ... of them offend at very high rates and commit more ... much later in life offend much less., "In a lot ...
(Date:4/14/2014)... with symptoms increasing dramatically during some of the most important ... has found. , Depressive symptoms increased on average by 68 ... young men, who were around 25 years old when they ... their children. The results of the study were published April ... is the first to identify when young fathers are at ...
(Date:4/14/2014)... Lower weight babies and babies who aren,t breastfed ... risk of developing chronic inflammation and related health ... study. , "There were good reasons to hypothesize ... inflammation in adulthood," says Thomas McDade (Northwestern University), ... in the Child & Brain Development program. "It ...
Breaking Medicine News(10 mins):Health News:Researchers identify children with emotional behavior difficulties 2Health News:Researchers identify children with emotional behavior difficulties 3Health News:Study links severe sleep apnea to increased risk of stroke, cancer and death 2Health News:UT Dallas study: Youth who fail to envision future commit more crimes 2Health News:Young dads at high risk of depression, too 2Health News:Low birth weight, less breastfeeding create later health risks 2
... clinic visits than African-American children with similar disease severity.// ... the past two decades, and minority populations have an ... of the journal Chest suggests that Puerto Rican children ... with similar disease severity, but that the latter spend ...
... mystery disease now called SARS emerged explosively out of ... in Asia, Europe, and North and South America—nearly one ... ,When scientists identified the virus that caused this sudden ... virus family whose other members cause many common colds. ...
... that many call centre employees between the ages of 19 ... caused due to insulin malfunction.// ,The Delhi Diabetes ... larger project. They explained that the epidemic of diabetes has ... country. They explained that there is now an increasing trend ...
... Mark Thomas, MD, an assistant professor and transplant surgeon ... performing the first pediatric laparoscopic liver// surgery. This procedure ... liver without first performing an incision. The operation was ... La Raza Pediatric Medical Hospital in Mexico City on ...
... Research conducted to better understand the mechanisms of micronutrient ... has led to findings// that make engineering nutrient-rich plants, ... also increasing crop biomass in soils now in cultivation, ... Guerinot at the Annual Meeting of the American Society ...
... saving drug that has been approved in Scotland, is ... ,Age-related macular degeneration (AMD) is the commonest cause ... has been approved yesterday by the Scottish Medicines Consortium ... Excellence (NICE) which covers England and Wales, is expected ...
Cached Medicine News:Health News:Children of Different Race Show Different Patterns of Asthma Care 2Health News:Researchers Find 'Secret Weapon' Used by SARS Virus 2Health News:Studies Find That Call Centre Employees Could Be More Prone to Diabetes 2Health News:World’s First Pediatric Laparoscopic Liver Surger 2Health News:World’s First Pediatric Laparoscopic Liver Surger 3Health News:Engineering Nutrient-Rich Plants Made For Feasible By New Findings 2Health News:Drug Denial may Leave Several Thousands Blind 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: